Clinical Trial Kits Market Size, Share & Trends Analysis Report By Service (Kitting Solutions, Logistics), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within Immediate
Clinical Trial Kits Market Growth & Trends
The global clinical trial kits market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.
Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.
COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.
Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.
Clinical Trial Kits Market Report Highlights
Clinical Trial Kits Market Growth & Trends
The global clinical trial kits market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.
Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.
COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.
Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.
Clinical Trial Kits Market Report Highlights
- The logistics segment dominated the market and accounted for the largest revenue share of 54.9% in 2020. This is due to the increasing demand for services to simplify the logistics process in clinical trials
- The phase III segment dominated the market and accounted for the largest revenue share of 53.4% in 2020 as phase III trials require a large number of participants
- North America dominated the market in 2020 owing to favorable government support and the existence of a large number of companies offering innovative services in the U.S.
- In Asia Pacific, the market is projected to witness the highest CAGR of 9.9% over the forecast period as the region is continuously growing in terms of clinical trials due to the vast population and developing technology
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective - 1:
1.9.2 Objective - 2:
1.9.3 Objective - 3:
1.9.4 Objective - 4:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 CLINICAL TRIAL KITS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Globalization of clinical trials
3.3.1.2 Increasing demand for remote services
3.3.1.3 Rising clinical trial complexity
3.3.2 Market Restraint Analysis
3.3.2.1 Varying regulations in countries
3.4 Clinical Trial Kits Market Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.4.3 Major deals & strategic alliances
3.4.3.1 Acquisitions
3.4.3.2 Partnerships
3.4.3.3 Expansion
3.4.3.4 Product launch
3.4.3.5 Collaboration
3.5 Clinical Trial Kits Market: Total Addressable Market (TAM) Analysis
3.5.1 Market Overview
CHAPTER 4 COVID-19 IMPACT
4.1 COVID-19 Impact on the market
4.2 COVID-19 Impact on the logistics
4.3 COVID-19 Pandemic Impact on Clinical Trial Activity
4.3.1 Obstacles in clinical trials
4.3.2 Disrupted clinical trials
4.3.2.1 Companies with Phase I trial disruption
4.3.2.2 Companies with Phase 2 trial disruption
4.3.2.3 Companies with Phase 3 trial disruption
CHAPTER 5 CLINICAL TRIAL KITS MARKET: SERVICE SEGMENT ANALYSIS
5.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
5.2 Kitting Solutions
5.2.1 Kitting solutions market, 2016 - 2028 (USD Million)
5.2.2 Drug Kits
5.2.2.1 Drug kits market, 2016 - 2028 (USD Million)
5.2.3 Sample Collection Kits
5.2.3.1 Sample collection kits market, 2016 - 2028 (USD Million)
5.3 Logistics
5.3.1 Logistics market, 2016 - 2028 (USD Million)
5.3.2 Transportation
5.3.2.1 Transportation market, 2016 - 2028 (USD Million)
5.3.3 Warehousing & storage
5.3.3.1 Warehousing & storage market, 2016 - 2028 (USD Million)
5.3.4 Others
5.3.4.1 Others market, 2016 - 2028 (USD Million)
CHAPTER 6 CLINICAL TRIAL KITS MARKET: PHASE SEGMENT ANALYSIS
6.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
6.2 Phase I
6.2.1 Phase I Market, 2016 - 2028 (USD Million)
6.3 Phase II
6.3.1 Phase II market, 2016 - 2028 (USD Million)
6.4 Phase III
6.4.1 Phase III market, 2016 - 2028 (USD Million)
6.5 Phase IV
6.5.1 Phase IV market, 2016 - 2028 (USD Million)
CHAPTER 7 CLINICAL TRIAL KITS MARKET: REGIONAL ANALYSIS
7.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America clinical trial kits market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clinical trial kits market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clinical trial kits market, 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Europe clinical trial kits market, 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. clinical trial kits market, 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Germany clinical trial kits market, 2016 - 2028 (USD Million)
7.3.4 France
7.3.4.1 France clinical trial kits market, 2016 - 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy clinical trial kits market, 2016 - 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain clinical trial kits market, 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clinical trial kits market, 2016 - 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clinical trial kits market, 2016 - 2028 (USD Million)
7.4.3 China
7.4.3.1 China clinical trial kits market, 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 India clinical trial kits market, 2016 - 2028 (USD Million)
7.4.5 Australia
7.4.5.1 Australia clinical trial kits market, 2016 - 2028 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea clinical trial kits market, 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America clinical trial kits market, 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clinical trial kits market, 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clinical trial kits market, 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina clinical trial kits market, 2016 - 2028 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia clinical trial kits market, 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 MEA clinical trial kits market, 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clinical trial kits market, 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia clinical trial kits market, 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 UAE clinical trial kits market, 2016 - 2028 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Company Profiles
8.1.1 Brooks Life Science
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.1.4 Strategy initiatives
8.1.2 Q2 solutions
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategy initiatives
8.1.3 Patheon (Thermo Fisher Scientific Inc)
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 ServicebBenchmarking
8.1.4 Labcorp Drug Development
8.1.4.1 Company overview
8.1.4.2 financial performance
8.1.4.3 Service benchmarking
8.1.4.4 Strategy initiatives
8.1.5 Charles River Laboratories
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Service benchmarking
8.1.6 LAbConnect
8.1.6.1 Company overview
8.1.6.2 Service Benchmarking
8.1.6.3 Strategy initiatives
8.1.7 Almac group
8.1.7.1 Company overview
8.1.7.2 Service benchmarking
8.1.7.3 Strategy initiatives
8.1.8 Precision Medicine Group
8.1.8.1 Company overview
8.1.8.2 Service benchmarking
8.1.8.3 Strategic initiatives
8.1.9 Cerba research
8.1.9.1 Company overview
8.1.9.2 Service benchmarking
8.1.10 Alpha laboratories
8.1.10.1 Company overview
8.1.10.2 Service benchmarking
8.1.11 Marken a UPS company
8.1.11.1 Company overview
8.1.11.2 Service benchmarking
8.1.11.3 Strategy initiatives
8.1.12 Clinigen
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 Service benchmarking
8.1.12.4 Strategy initiatives
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Phase
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective - 1:
1.9.2 Objective - 2:
1.9.3 Objective - 3:
1.9.4 Objective - 4:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 CLINICAL TRIAL KITS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Globalization of clinical trials
3.3.1.2 Increasing demand for remote services
3.3.1.3 Rising clinical trial complexity
3.3.2 Market Restraint Analysis
3.3.2.1 Varying regulations in countries
3.4 Clinical Trial Kits Market Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.4.3 Major deals & strategic alliances
3.4.3.1 Acquisitions
3.4.3.2 Partnerships
3.4.3.3 Expansion
3.4.3.4 Product launch
3.4.3.5 Collaboration
3.5 Clinical Trial Kits Market: Total Addressable Market (TAM) Analysis
3.5.1 Market Overview
CHAPTER 4 COVID-19 IMPACT
4.1 COVID-19 Impact on the market
4.2 COVID-19 Impact on the logistics
4.3 COVID-19 Pandemic Impact on Clinical Trial Activity
4.3.1 Obstacles in clinical trials
4.3.2 Disrupted clinical trials
4.3.2.1 Companies with Phase I trial disruption
4.3.2.2 Companies with Phase 2 trial disruption
4.3.2.3 Companies with Phase 3 trial disruption
CHAPTER 5 CLINICAL TRIAL KITS MARKET: SERVICE SEGMENT ANALYSIS
5.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
5.2 Kitting Solutions
5.2.1 Kitting solutions market, 2016 - 2028 (USD Million)
5.2.2 Drug Kits
5.2.2.1 Drug kits market, 2016 - 2028 (USD Million)
5.2.3 Sample Collection Kits
5.2.3.1 Sample collection kits market, 2016 - 2028 (USD Million)
5.3 Logistics
5.3.1 Logistics market, 2016 - 2028 (USD Million)
5.3.2 Transportation
5.3.2.1 Transportation market, 2016 - 2028 (USD Million)
5.3.3 Warehousing & storage
5.3.3.1 Warehousing & storage market, 2016 - 2028 (USD Million)
5.3.4 Others
5.3.4.1 Others market, 2016 - 2028 (USD Million)
CHAPTER 6 CLINICAL TRIAL KITS MARKET: PHASE SEGMENT ANALYSIS
6.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
6.2 Phase I
6.2.1 Phase I Market, 2016 - 2028 (USD Million)
6.3 Phase II
6.3.1 Phase II market, 2016 - 2028 (USD Million)
6.4 Phase III
6.4.1 Phase III market, 2016 - 2028 (USD Million)
6.5 Phase IV
6.5.1 Phase IV market, 2016 - 2028 (USD Million)
CHAPTER 7 CLINICAL TRIAL KITS MARKET: REGIONAL ANALYSIS
7.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America clinical trial kits market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. clinical trial kits market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada clinical trial kits market, 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Europe clinical trial kits market, 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. clinical trial kits market, 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Germany clinical trial kits market, 2016 - 2028 (USD Million)
7.3.4 France
7.3.4.1 France clinical trial kits market, 2016 - 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy clinical trial kits market, 2016 - 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain clinical trial kits market, 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific clinical trial kits market, 2016 - 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan clinical trial kits market, 2016 - 2028 (USD Million)
7.4.3 China
7.4.3.1 China clinical trial kits market, 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 India clinical trial kits market, 2016 - 2028 (USD Million)
7.4.5 Australia
7.4.5.1 Australia clinical trial kits market, 2016 - 2028 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea clinical trial kits market, 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America clinical trial kits market, 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil clinical trial kits market, 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico clinical trial kits market, 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina clinical trial kits market, 2016 - 2028 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia clinical trial kits market, 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 MEA clinical trial kits market, 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa clinical trial kits market, 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia clinical trial kits market, 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 UAE clinical trial kits market, 2016 - 2028 (USD Million)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Company Profiles
8.1.1 Brooks Life Science
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.1.4 Strategy initiatives
8.1.2 Q2 solutions
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategy initiatives
8.1.3 Patheon (Thermo Fisher Scientific Inc)
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 ServicebBenchmarking
8.1.4 Labcorp Drug Development
8.1.4.1 Company overview
8.1.4.2 financial performance
8.1.4.3 Service benchmarking
8.1.4.4 Strategy initiatives
8.1.5 Charles River Laboratories
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Service benchmarking
8.1.6 LAbConnect
8.1.6.1 Company overview
8.1.6.2 Service Benchmarking
8.1.6.3 Strategy initiatives
8.1.7 Almac group
8.1.7.1 Company overview
8.1.7.2 Service benchmarking
8.1.7.3 Strategy initiatives
8.1.8 Precision Medicine Group
8.1.8.1 Company overview
8.1.8.2 Service benchmarking
8.1.8.3 Strategic initiatives
8.1.9 Cerba research
8.1.9.1 Company overview
8.1.9.2 Service benchmarking
8.1.10 Alpha laboratories
8.1.10.1 Company overview
8.1.10.2 Service benchmarking
8.1.11 Marken a UPS company
8.1.11.1 Company overview
8.1.11.2 Service benchmarking
8.1.11.3 Strategy initiatives
8.1.12 Clinigen
8.1.12.1 Company overview
8.1.12.2 Financial performance
8.1.12.3 Service benchmarking
8.1.12.4 Strategy initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global clinical trial kits market, by region, 2016 & 2028 (USD Million)
Table 4 Global clinical trial kits market, by service, 2016 & 2028 (USD Milion)
Table 5 Global clinical trial kits market, by phase, 2016 & 2028 (USD Million)
Table 6 North America clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 7 North America clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 8 North America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 9 U.S. clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 10 U.S. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 11 Canada clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 12 Canada clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 13 Europe clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 14 Europe clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 15 Europe clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 16 U.K. clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 17 U.K. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 18 Germany clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 19 Germany clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 20 Spain clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 21 Spain clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 22 France clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 23 France clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 24 Italy clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 25 Italy clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 26 Asia Pacific clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 27 Asia Pacific clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 28 Asia Pacific clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 29 China clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 30 China clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 31 India clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 32 India clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 33 Japan clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 34 Japan clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 35 Australia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 36 Australia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 37 South Korea clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 38 South Korea clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 39 Latin America clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 40 Latin America clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 41 Latin America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 42 Brazil clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 43 Brazil clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 44 Mexico clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 45 Mexico clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 46 Argentina clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 47 Argentina clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 48 Colombia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 49 Colombia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 50 MEA clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 51 MEA clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 52 MEA clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 53 South Africa clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 54 South Africa clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 55 Saudi Arabia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 56 Saudi Arabia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 57 UAE clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 58 UAE clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global clinical trial kits market, by region, 2016 & 2028 (USD Million)
Table 4 Global clinical trial kits market, by service, 2016 & 2028 (USD Milion)
Table 5 Global clinical trial kits market, by phase, 2016 & 2028 (USD Million)
Table 6 North America clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 7 North America clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 8 North America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 9 U.S. clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 10 U.S. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 11 Canada clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 12 Canada clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 13 Europe clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 14 Europe clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 15 Europe clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 16 U.K. clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 17 U.K. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 18 Germany clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 19 Germany clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 20 Spain clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 21 Spain clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 22 France clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 23 France clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 24 Italy clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 25 Italy clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 26 Asia Pacific clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 27 Asia Pacific clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 28 Asia Pacific clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 29 China clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 30 China clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 31 India clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 32 India clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 33 Japan clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 34 Japan clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 35 Australia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 36 Australia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 37 South Korea clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 38 South Korea clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 39 Latin America clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 40 Latin America clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 41 Latin America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 42 Brazil clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 43 Brazil clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 44 Mexico clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 45 Mexico clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 46 Argentina clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 47 Argentina clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 48 Colombia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 49 Colombia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 50 MEA clinical trial kits market, by region, 2016 - 2028 (USD Million)
Table 51 MEA clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 52 MEA clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 53 South Africa clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 54 South Africa clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 55 Saudi Arabia clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 56 Saudi Arabia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
Table 57 UAE clinical trial kits market, by service, 2016 - 2028 (USD Million)
Table 58 UAE clinical trial kits market, by phase, 2016 - 2028 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Clinical trial kits snapshot (2020)
Fig. 9 Clinical trial kits market segmentation
Fig. 10 Clinical trial kits market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Companies with affected trials, by size
Fig. 19 Affected trials, by study phase
Fig. 20 Clinical trial kits market service: Segment dashboard
Fig. 21 Clinical trial kits market: Service movement analysis
Fig. 22 Kitting solutions market, 2016 - 2028 (USD Million)
Fig. 23 Drug kits market, 2016 - 2028 (USD Million)
Fig. 24 Sample collection kits market, 2016 - 2028 (USD Million)
Fig. 25 Logistics market, 2016 - 2028 (USD Million)
Fig. 26 Transportation market, 2016 - 2028 (USD Million)
Fig. 27 Warehousing & storage market, 2016 - 2028 (USD Million)
Fig. 28 Others market, 2016 - 2028 (USD Million)
Fig. 29 Clinical trial kits market phase outlook: Segment dashboard
Fig. 30 Clinical trial kits market: Phase movement analysis
Fig. 31 Phase I market, 2016 - 2028 (USD Million)
Fig. 32 Phase II market, 2016 - 2028 (USD Million)
Fig. 33 Phase III market, 2016 - 2028 (USD Million)
Fig. 34 Phase IV market, 2016 - 2028 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2020 2028
Fig. 37 North America market, 2016 - 2028 (USD Million)
Fig. 38 U.S. market, 2016 - 2028 (USD Million)
Fig. 39 Canada market, 2016 - 2028 (USD Million)
Fig. 40 Europe market, 2016 - 2028 (USD Million)
Fig. 41 U.K. market, 2016 - 2028 (USD Million)
Fig. 42 Germany market, 2016 - 2028 (USD Million)
Fig. 43 France market, 2016 - 2028 (USD Million)
Fig. 44 Italy market, 2016 - 2028 (USD Million)
Fig. 45 Spain market, 2016 - 2028 (USD Million)
Fig. 46 Asia Pacific market, 2016 - 2028 (USD Million)
Fig. 47 Japan market, 2016 - 2028 (USD Million)
Fig. 48 China market, 2016 - 2028 (USD Million)
Fig. 49 India market, 2016 - 2028 (USD Million)
Fig. 50 Australia market, 2016 - 2028 (USD Million)
Fig. 51 South Korea market, 2016 - 2028 (USD Million)
Fig. 52 Latin America market, 2016 - 2028 (USD Million)
Fig. 53 Brazil market, 2016 - 2028 (USD Million)
Fig. 54 Mexico market, 2016 - 2028 (USD Million)
Fig. 55 Argentina market, 2016 - 2028 (USD Million)
Fig. 56 Colombia market, 2016 - 2028 (USD Million)
Fig. 57 MEA market, 2016 - 2028 (USD Million)
Fig. 58 South Africa market, 2016 - 2028 (USD Million)
Fig. 59 Saudi Arabia market, 2016 - 2028 (USD Million)
Fig. 60 UAE market, 2016 - 2028 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Clinical trial kits snapshot (2020)
Fig. 9 Clinical trial kits market segmentation
Fig. 10 Clinical trial kits market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Companies with affected trials, by size
Fig. 19 Affected trials, by study phase
Fig. 20 Clinical trial kits market service: Segment dashboard
Fig. 21 Clinical trial kits market: Service movement analysis
Fig. 22 Kitting solutions market, 2016 - 2028 (USD Million)
Fig. 23 Drug kits market, 2016 - 2028 (USD Million)
Fig. 24 Sample collection kits market, 2016 - 2028 (USD Million)
Fig. 25 Logistics market, 2016 - 2028 (USD Million)
Fig. 26 Transportation market, 2016 - 2028 (USD Million)
Fig. 27 Warehousing & storage market, 2016 - 2028 (USD Million)
Fig. 28 Others market, 2016 - 2028 (USD Million)
Fig. 29 Clinical trial kits market phase outlook: Segment dashboard
Fig. 30 Clinical trial kits market: Phase movement analysis
Fig. 31 Phase I market, 2016 - 2028 (USD Million)
Fig. 32 Phase II market, 2016 - 2028 (USD Million)
Fig. 33 Phase III market, 2016 - 2028 (USD Million)
Fig. 34 Phase IV market, 2016 - 2028 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2020 2028
Fig. 37 North America market, 2016 - 2028 (USD Million)
Fig. 38 U.S. market, 2016 - 2028 (USD Million)
Fig. 39 Canada market, 2016 - 2028 (USD Million)
Fig. 40 Europe market, 2016 - 2028 (USD Million)
Fig. 41 U.K. market, 2016 - 2028 (USD Million)
Fig. 42 Germany market, 2016 - 2028 (USD Million)
Fig. 43 France market, 2016 - 2028 (USD Million)
Fig. 44 Italy market, 2016 - 2028 (USD Million)
Fig. 45 Spain market, 2016 - 2028 (USD Million)
Fig. 46 Asia Pacific market, 2016 - 2028 (USD Million)
Fig. 47 Japan market, 2016 - 2028 (USD Million)
Fig. 48 China market, 2016 - 2028 (USD Million)
Fig. 49 India market, 2016 - 2028 (USD Million)
Fig. 50 Australia market, 2016 - 2028 (USD Million)
Fig. 51 South Korea market, 2016 - 2028 (USD Million)
Fig. 52 Latin America market, 2016 - 2028 (USD Million)
Fig. 53 Brazil market, 2016 - 2028 (USD Million)
Fig. 54 Mexico market, 2016 - 2028 (USD Million)
Fig. 55 Argentina market, 2016 - 2028 (USD Million)
Fig. 56 Colombia market, 2016 - 2028 (USD Million)
Fig. 57 MEA market, 2016 - 2028 (USD Million)
Fig. 58 South Africa market, 2016 - 2028 (USD Million)
Fig. 59 Saudi Arabia market, 2016 - 2028 (USD Million)
Fig. 60 UAE market, 2016 - 2028 (USD Million)
